Isaac Zacharias - 15 Nov 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
/s/ Wade Estey, as attorney in fact for Isaac Zacharias
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
-$824,658
Form type
4
Filing time
16 Nov 2021, 16:22:03 UTC
Previous filing
18 Oct 2021
Next filing
16 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $40,028 -200 -0.39% $200.14 51,220 15 Nov 2021 Direct F1, F2
transaction SWAV Common Stock Sale $80,436 -400 -0.78% $201.09 50,820 15 Nov 2021 Direct F3
transaction SWAV Common Stock Sale $80,808 -400 -0.79% $202.02 50,420 15 Nov 2021 Direct F4
transaction SWAV Common Stock Sale $61,173 -300 -0.6% $203.91 50,120 15 Nov 2021 Direct F5
transaction SWAV Common Stock Sale $225,277 -1,098 -2.2% $205.17 49,022 15 Nov 2021 Direct F6
transaction SWAV Common Stock Sale $20,589 -100 -0.2% $205.89 48,922 15 Nov 2021 Direct F7
transaction SWAV Common Stock Sale $146,199 -702 -1.4% $208.26 48,220 15 Nov 2021 Direct F8
transaction SWAV Common Stock Sale $20,969 -100 -0.21% $209.69 48,120 15 Nov 2021 Direct F9
transaction SWAV Common Stock Sale $84,464 -400 -0.83% $211.16 47,720 15 Nov 2021 Direct F10
transaction SWAV Common Stock Sale $21,178 -100 -0.21% $211.78 47,620 15 Nov 2021 Direct F11
transaction SWAV Common Stock Sale $43,538 -200 -0.42% $217.69 47,420 15 Nov 2021 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/14/2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $199.80 to $200.48. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $200.85 to $201.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $202.00 to $202.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $203.57 to $204.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.65 to $205.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The reported securities were sold at a price of $205.89.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.89 to $208.68. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F9 The reported securities were sold at a price of $209.69.
F10 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.75 to $211.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F11 The reported securities were sold at a price of $211.78.
F12 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.68 to $217.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.